New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 6, 2012
19:03 EDTBSXBoston Scientific clinical trial shows device programming reduces risk of death
Boston Scientific Corporation and the University of Rochester Medical Center presented positive results from the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy clinical trial that demonstrated improved programming of Boston Scientific dual-chamber implantable cardioverter defibrillator or cardiac resynchronization therapy defibrillator heart devices can reduce inappropriate therapy and risk of death. The study was designed to determine if alternate programming could reduce the occurrence of inappropriate therapy in primary prevention patients.
News For BSX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 23, 2015
12:35 EDTBSXBoston Scientific CEO says M&A an important strategy
Boston Scientific CEO is speaking in a CNBC interview.
07:25 EDTBSXPiper Jaffray to hold a summit
2015 Piper Jaffray Heartland Summit is being held in Minneapolis on June 23-24.
June 22, 2015
09:04 EDTBSXBoston Scientific initiates study to assess EMBLEM S-ICD
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use